A detailed history of Meridian Investment Counsel Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Meridian Investment Counsel Inc. holds 27,834 shares of ABBV stock, worth $4.97 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
27,834
Previous 28,534 2.45%
Holding current value
$4.97 Million
Previous $4.89 Million 12.3%
% of portfolio
1.69%
Previous 1.57%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $114,688 - $139,531
-700 Reduced 2.45%
27,834 $5.5 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $26,933 - $31,452
-174 Reduced 0.61%
28,534 $4.89 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $105,641 - $120,368
-661 Reduced 2.25%
28,708 $5.23 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $9,356 - $10,537
-68 Reduced 0.23%
29,369 $4.55 Million
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $138,265 - $160,062
-1,035 Reduced 3.4%
29,437 $4.39 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $3,615 - $4,163
-25 Reduced 0.08%
30,472 $4.86 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $2,351 - $2,819
17 Added 0.06%
30,497 $4.93 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 0.33%
30,480 $4.09 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $29,863 - $37,966
-217 Reduced 0.7%
30,580 $4.68 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $65,330 - $81,056
-495 Reduced 1.58%
30,797 $4.99 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $128,378 - $162,436
-1,195 Reduced 3.68%
31,292 $4.24 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $8,831 - $10,024
-83 Reduced 0.25%
32,487 $3.5 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $24,303 - $27,075
231 Added 0.71%
32,570 $3.67 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $33,247 - $36,601
325 Added 1.02%
32,339 $3.5 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $23,744 - $32,057
295 Added 0.93%
32,014 $3.43 Million
Q3 2020

Oct 23, 2020

SELL
$85.91 - $100.83 $91,494 - $107,383
-1,065 Reduced 3.25%
31,719 $2.78 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $11,298 - $15,119
154 Added 0.47%
32,784 $3.22 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $236,392 - $358,400
3,665 Added 12.65%
32,630 $2.49 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $21,639 - $27,075
300 Added 1.05%
28,965 $2.57 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $218,855 - $263,127
3,475 Added 13.8%
28,665 $2.17 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $16,096 - $20,575
245 Added 0.98%
25,190 $1.83 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $17,356 - $20,427
-225 Reduced 0.89%
24,945 $2.01 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $68,118 - $84,008
-875 Reduced 3.36%
25,170 $2.32 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $4,445 - $4,942
-50 Reduced 0.19%
26,045 $2.46 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $6,284 - $7,436
-70 Reduced 0.27%
26,095 $2.42 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $34,503 - $46,203
-375 Reduced 1.41%
26,165 $2.48 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $1,522 - $1,669
17 Added 0.06%
26,540 $2.57 Million
Q2 2017

Aug 14, 2017

BUY
N/A
26,523
26,523 $1.92 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Meridian Investment Counsel Inc. Portfolio

Follow Meridian Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.